CIK 0002020932 · Non-accelerated filer<br>Emerging growth company
AgomAb Therapeutics NV
Sign in to watch- Ticker
- AGMB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Belgium
- Entity type
- other
- Phone
- 32 3 302 35 30
- Business address
- POSTHOFLEI 1/6, ANTWERPEN, Belgium, 2600
- 424B4 Offering Prospectus
- CERT Other Certification
- 8-A12B Other Registration of Securities
- EFFECT Other Notice of Effectiveness
- F-1/A Offering Registration Statement for Certain Foreign Private Issuers
- F-1 Offering Registration Statement for Certain Foreign Private Issuers
- DRS/A Other Draft Registration Statement
- DRS/A Other Draft Registration Statement
- DRS Other Draft Registration Statement
Page 3 of 3 · 49 filings